Skip to content
DiseaseQ3500973· pop 8· linked from 27 articles

lipoatrophy

Sign in to save

Lipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutaneous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutaneous injections of copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy occurs in HIV-associated lipodystrophy, one cause of which is an adverse drug reaction that is associated with some antiretroviral medications.

Clinical Trials

216 registered

via ClinicalTrials.gov

~1 min read

Article

1 sections
Contents
  • References

Lipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutaneous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutaneous injections of copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy occurs in HIV-associated lipodystrophy, one cause of which is an adverse drug reaction that is associated with some antiretroviral medications.

A more general term for an abnormal or degenerative condition of the entire body's adipose tissue is lipodystrophy.

Available in 8 languages

via Wikidata sitelinks · CC0

Connections

Categories